Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

5HJS

Identification of LXRbeta selective agonists for the treatment of Alzheimer's Disease

5HJS の概要
エントリーDOI10.2210/pdb5hjs/pdb
関連するPDBエントリー5HJP
分子名称Oxysterols receptor LXR-alpha, Nuclear receptor coactivator 1, 2-chloro-4-{1'-[(2R)-2-hydroxy-3-methyl-2-(trifluoromethyl)butanoyl]-4,4'-bipiperidin-1-yl}-N,N-dimethylbenzamide, ... (5 entities in total)
機能のキーワードagonist, alzheimer's, signaling protein
由来する生物種Homo sapiens (Human)
詳細
細胞内の位置Nucleus : Q13133 Q15788
タンパク質・核酸の鎖数4
化学式量合計72573.26
構造登録者
Parthasarathy, G.,Klein, D. (登録日: 2016-01-13, 公開日: 2016-04-06, 最終更新日: 2024-03-06)
主引用文献Stachel, S.J.,Zerbinatti, C.,Rudd, M.T.,Cosden, M.,Suon, S.,Nanda, K.K.,Wessner, K.,DiMuzio, J.,Maxwell, J.,Wu, Z.,Uslaner, J.M.,Michener, M.S.,Szczerba, P.,Brnardic, E.,Rada, V.,Kim, Y.,Meissner, R.,Wuelfing, P.,Yuan, Y.,Ballard, J.,Holahan, M.,Klein, D.J.,Lu, J.,Fradera, X.,Parthasarathy, G.,Uebele, V.N.,Chen, Z.,Li, Y.,Li, J.,Cooke, A.J.,Bennett, D.J.,Bilodeau, M.T.,Renger, J.
Identification and in Vivo Evaluation of Liver X Receptor beta-Selective Agonists for the Potential Treatment of Alzheimer's Disease.
J.Med.Chem., 59:3489-3498, 2016
Cited by
PubMed Abstract: Herein, we describe the development of a functionally selective liver X receptor β (LXRβ) agonist series optimized for Emax selectivity, solubility, and physical properties to allow efficacy and safety studies in vivo. Compound 9 showed central pharmacodynamic effects in rodent models, evidenced by statistically significant increases in apolipoprotein E (apoE) and ATP-binding cassette transporter levels in the brain, along with a greatly improved peripheral lipid safety profile when compared to those of full dual agonists. These findings were replicated by subchronic dosing studies in non-human primates, where cerebrospinal fluid levels of apoE and amyloid-β peptides were increased concomitantly with an improved peripheral lipid profile relative to that of nonselective compounds. These results suggest that optimization of LXR agonists for Emax selectivity may have the potential to circumvent the adverse lipid-related effects of hepatic LXR activity.
PubMed: 27011007
DOI: 10.1021/acs.jmedchem.6b00176
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.72 Å)
構造検証レポート
Validation report summary of 5hjs
検証レポート(詳細版)ダウンロードをダウンロード

248636

件を2026-02-04に公開中

PDB statisticsPDBj update infoContact PDBjnumon